FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to pharmacology, and concerns application of 3-(piperidinomethyl)thiazolo [3,2-a] benzimidazole dihydrochloride as a corrector of haemorheological disturbances in the conditions complicated with blood hyperviscosity syndrome.
EFFECT: compound exhibits high haemorheological activity surpassing such of pentoxyfylline, while being less toxic.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 2-[1-(1,1-DIOXOTHIETANYL-3)-1,2,4-TRIASOLYL-5-THIO]ACETIC ACID, POSSESSING HEMORRHEOLOGIC ACTIVITY | 2007 |
|
RU2339632C1 |
| HYDROCHLORIDE 8-AMINO-7-(2-HYDROXYPROPYL-1)-1,3-DIMETHYLXANTHINE DERIVATIVES DISPLAYING HAEMORHEOLOGICAL ACTIVITY | 2007 |
|
RU2344137C1 |
| DERIVATIVES OF 3-METHYL-7-(THETANYL-3)-XANTHINE POSSESSING HEMORHEOLOGICAL ACTIVITY | 2006 |
|
RU2316551C1 |
| 3-CYCLOHEXYLAMINOMETHYLTHIAZOLE[3,2-a]BENZIMIDAZOLE DIHYDROCHLORIDE HAVING IMMUNOTROPIC AND ANTI-AGGREGATION ACTIVITY | 2009 |
|
RU2405788C1 |
| HAEMOSTASIS SYSTEM CORRECTOR MANIFESTING INHIBITORY ACTION ON ADHESIVE AGGREGATIVE FUNCTION OF THROMBOCYTES TO PREVENT PATHOLOGICAL THROMBOSIS | 2008 |
|
RU2373929C1 |
| METHOD FOR EVALUATING SEVERITY OF DISTURBED RED BLOOD CELL AGGREGATION | 2009 |
|
RU2447450C2 |
| THERAPY OF PATIENTS SUFFERING FROM ESSENTIAL HYPERTENSION | 2008 |
|
RU2364429C1 |
| 9-SUBSTITUTED 2-HALOGENPHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE SALTS AND 1-SUBSTITUTED 3-HALOGENPHENACYL-2-AMINOBENZIMIDAZOLIUM HALIDES POSSESSING HEMORHEOLOGICAL PROPERTIES | 2005 |
|
RU2290404C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC HEART DISEASE AND ACCOMPANYING TYPE 2 DIABETES | 2009 |
|
RU2411050C1 |
| THERAPY OF CHRONIC LOWER LIMB ISCHEMIA | 2008 |
|
RU2367477C1 |
